SoftBank Group, opens new tab CEO Masayoshi Son said on Monday he has agreed with OpenAI CEO Sam Altman to set up a joint venture in Japan to offer artificial intelligence services to corporate customers.
The Japanese investment giant will also pay $3 billion annually to use OpenAI's technology across SoftBank group companies.
The joint venture, SB OpenAI Japan, will be owned by OpenAI and a company established by SoftBank and its domestic telecoms arm.
Son is moving to deepen his exposure to OpenAI, with SoftBank looking at investing $15 billion to $25 billion in the company, Reuters reported last week.
SoftBank is also committing $15 billion to Stargate, a joint venture with OpenAI and Oracle (ORCL.N), opens new tab to build AI capacity in the U.S., Reuters has reported.
The Stargate launch last month saw Son make his second appearance with Donald Trump since his election as president in November.
Son's backing for OpenAI reflects his reemergence as an investment force after a period of retrenchment sparked by the falling value of SoftBank's tech portfolio and a series of high profile stumbles.
He has a long history of partnering with tech firms in the U.S., with SoftBank bringing the iPhone to Japan in 2008.
Read next
17:00
Kyrgyzstan
Kyrgyzstan has announced the creation of an interagency task force aimed at supervising and enhancing laboratory testing for agricultural products, the Ministry of Water Resources, Agriculture, and Processing Industry said on Sunday.
16:48
Ukraine-Russia War
Ukrainian and Russian delegations have begun a new round of peace talks in Istanbul, with Kyiv pushing for a ceasefire, prisoner exchange, and humanitarian measures, while Moscow continues to withhold its official terms and demands concessions unlikely to be accepted by Ukraine.
16:30
Kyrgyzstan
The construction of Kyrgyzstan’s Orto-Tokoy Hydropower Plant (HPP) has reached the halfway mark, with 50% of the work completed, the Ministry of Energy announced on Sunday.
16:15
French pharmaceutical giant Sanofi announced Monday that it will acquire U.S.-based Blueprint Medicines for $9.1 billion to strengthen its portfolio in rare immunological diseases.
16:00
Asian markets
Stock markets across Asia tumbled Monday after U.S. President Donald Trump announced a new round of tariff hikes on Chinese imports, sparking renewed fears of a deepening U.S.–China trade war.
What is your opinion on this topic?
Leave the first comment